Replication of ds RNA Viruses Flashcards

1
Q

Family Reoviridae

A

Genera
- Orbivirus (Bluetongue virus); epizooty
- Rotavirus (human RV); diarrhea associated diseases in children
- Orthoreovirus
- a.o.

Genome
- segmented dsRNA, 10 - 12 segments
- 18 - 27 kB
- e.g. Bluetongue: 19.2 kb in 10 segments

Virion structure
- Complex, 3-layered protein shell
- Insensitive to detergents (non-enveloped)
- Glycoproteins

Reovirus architecture
- Infectious sub viral particle (2 layers)
- Core (1 layer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Replicative cycle

A
  • Receptor binding and endocytosis
  • Acid-induced proteolysis of the virion within the endosome (see 6) = conversion of the virion into the infectious subviral particle (ISVP)
  • Proteolytic conversion can take place already in the intestine
  • Can penetrate through endosomal membrane into cytoplasm
  • Cytoplasm: Conversion form IVSP to core particle
  • Synthesis of capped viral mRNAs takes place in the core particle
  • Association of mRNAs with newly translated proteins to RNase-sensitive sub viral particles SVP
  • “Transcription” of mRNAs into (-)-strand RNA and formation of RNase resistent SVP with 10 dsRNA segments (reassortment?)
  • Formation of virions by assembly of preformed outer capsid proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Cell entry of reoviruses

A
  • Hemagglutinin binds cellular receptor
  • Receptor mediates endocytosis into the endosome
  • Proteolysis leads to ISVP and allows penetration through endosomal membrane
  • Conversion into core particle; place of mRNA synthesis
  • RNase insensitive
  • Allows entry of nucleotides and start of mRNA transcription
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

3-layered reovirus-particle

A

insensitive to detergents

Stepwise dissociation:
Virion: VP1, 2, 3, 4, 6, 7
ISVP: VP1, 2, 3, 6
Core: VP1, 2, 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Function of rotaviral structural proteins

A

VP1: RdRp, forms protein bridge between 5 ́and 3 ́ends of the genome segments
VP2: RNA binding; essential for activity of VP1
VP3: Guanylyltranserfase, methyltransferase, ssRNA binding, in complex with VP1
VP4: Hemagglutinin, fusion protein (?), cleavage required before fusion
VP6: Trimer, essential for transcription, transcriptional pore
VP7: Ca2+ dep. trimeric membrane glycoprotein in the outer capsid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Functions of reoviral proteins

A

VP1: RdRp, forms protein bridge between 5 ́and 3 ́ends of the genome segments, in complex with VP3
VP2: RNA binding; inner layer in the core, essential for activity of VP1/VP3 complex
VP3: Guanylyltranserfase, methyltransferase, ssRNA binding, in complex with VP1 (capping!)
VP4: Hemagglutinin, fusion protein, cleavage into VP5,VP8 is required for fusion
VP6: Trimer, essential for transcription
VP7: Ca2+ dep. trimeric membrane glycoprotein in the outer capsid
NSP1: Zn-finger, RNA binding, IRF3 (interferon system) antagonist
NSP2: RNA binding, oligomer, helicase/NTPase, forms viroplasm with NSP5
NSP3: Dimer, binds 3 ́end of viral mRNAs, competes with PABP for eIF4G-1 binding, so prevents cyclization and translation of cell. mRNAs
NSP4: Membrane glycoprotein at ER, involved in assembly, interacts with viroplasm
NSP5: Phosphoprotein, RNA binding, protein kinase, forms viroplasm with NSP2
NSP6: Interacts with NSP5, is inside the viroplasm
Naked RNA ist not infectious! dsRNA is never naked, always together with viral proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

RNA Transcription in double layered core particle of Rotaviruses

A
  • newly synthesised mRNAs emerge from particles
  • mRNAs leaves core particles through channels
  • at the bottom of each channel resides a complex of VP1 (polymerase) and VP3 (guanylyltransferase, capping enzyme)
  • at each five fold axis one genome segment may be replicated (max. 12, due to 12-fold symmetry)
    -> Orthoreoviruses in contrast have ISVPs with one protein layer!
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Genome replication

A
  • Conserved UGUG motif recognized in all segments by RdRp
  • Panhandle structure: interaction of 5 ́and 3 ́end of each segment (base pairing)
  • Non-coding sequences contain packaging- and assembly-signals
  • dsRNA is synthesized in simultaniously forming subviral particles
  • Viroplasm: area of RNA replication in the cytoplasm
  • Subviral particles mature at the viroplasm, bud into the ER and receive thereby the outer capsid proteins (glycoproteins)
    -> VP4 and VP7 are essential for infection process, but not for RNA replication
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Fusion of reovirus ISVP with endosome membrane

A
  • μ1N peptide and theta peptide, both cleavage products of μ1 protein contribute to pore formation
  • μ1N peptide alone is sufficient to form a pore in the target membrane
  • ISVP are then recruited to the pores, docking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Blue tongue disease

A

A mainly acute developing, seasonal disease of sheep, cattle, goat and wild ruminants
transmission via gnats
Pathogen is very variable (24 serotypes with different virulence)
Distribution: Africa, North- and Middle-America, Asia, Australia, southern Europa (Spain, Portugal, Greek, Italy, Bulgary, Turkey, …)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bluetongue Virus

A

Taxonomy
Family: Reoviridae
Genera: Orthoreovirus
Orbivirus
Rotavirus
Coltivirus
Aquareovirus

Virions
Size: 60-80 nm; non enveloped
Capsid (Icosahedron)
several protein shells; ISVP
Genome: dsRNA, 18-27 kb 10-12 segments; reassortment
Replication: in cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Blue tongue disease -> Clinics

A

Incubation periode: 3-7 days
Acute progression (sheep)
Fever, hyperemia of oral and nasal mucosa, Lips- and tongue-edema, blue colouring of the tongue (rare), purulent rhinitis, dyspnea, erosion and ulceration at the mucosa, claw inflammation, degenerative changes in the skeletal-muscles, lameness, redness of skin (wool becomes brittle or sheds); diarrhea in young animals, death often within a week

Subacute progression
Symptoms similar, but less grave, also clinical inapparent infections

Cattle
mostly mild progression
Guiding symptoms: ulceration, necrosis, salivation, redness, edema, inappetence, lameness (muscle- / claw inflammation), erythema, edema at the udder and vulva, decrease of milk yield
Morbidity
sheep: high (depending on the race)
cattle: ca. 5% (can be higher)
Letality
very variable (sheep: 2-40%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Blue tongue disease -> Pathogenesis

A

Commuication via gnat bites -> primary proliferation in the lymphatic tissue -> Viremia (erythrocytes), affinity to the endothelium small bloodvessel -> destruction of endothelial cells
-> vasoconstriction, stasis, exudation
-> circulation failure, edema, diapedesis-
bleeding, inflammational hyperemia

Claw changes due to blood stasis epithel- and muscle damages due to capillary coaggluation necrosis

After diaplacentary infection (5./6. week of pregnancy): misscarriages, fetopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Blue tongue disease -> Epidemiology

A

Transmission of the pathogen via gnats (Culicoides)

Proliferation in salivary gland of arthropods
(arbovirus = artropode borne virus)

Spreading of the virus mainly during rainy season in summer (dep. on the time of flight of the gnats). Contact infections are unknown.

Viral reservoir:
Inapparently infected cattle, goats and wild ruminants
Hibernation: larvea of gnats? Yes!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Blue tongue disease -> Entry of BTV-serotypes into Europe since 1998

A
  • 6 BTV-strains (1, 2, 4, 8, 9, 16)
  • 16 countries
    Reasons:
  • climatic changes
  • spreading of C. imicola
  • local punkies as vectors

-> Illegal vaccine triggers a second blue tongue outbreak

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

BTV: vectors in Europe

A
  • C. obsoletus
  • C. pulicaris
  • C. imicola (since 1998)
  • C. imicola (before 1998)
17
Q

Blue tongue disease -> Diagnosis

A

Clinical symptoms: -> suspicion

Pathogen-/Ab-detection
RT-PCR, ELISA,
Virus propagation in cell culture and chicken eggs, experimental infections in sheeps

Ab-detection
ELISA, NT (HAH, AGPT: Agar gel
precipitation test and others) types differentiation: NT, HAH

Differential diagnosis
FMD (Picornav.), Orf (Poxv.), BKF (Herpes Virus), BVD/MD (Pestivirus), Rinderpest
(Morbilliv.), VS (VSV), other Reoviridae: Ibaraki (cattle), EHD (deer)

18
Q

Blue tongue disease -> Countering and control

A

Duty of disclosure (in all EU-states)

2003: settlement for the formation of a hazard zone (20 km) and monitoring zone (150 km) at first appearance of blue tongue disease (German „Tierseuchenrecht“)

„Verbringungsverbote“ (legal prohibition of transfer)

Monitoring of animals suspected of being infected (clinical testing , laboratory diagnostics)

Export stop for cattle and sheeps from regions with documented infections

Quarantine measures

Insect killing

19
Q

Blue tongue disease -> Countering and Control -> Monitoring

A

-> Detection of new BTV-infections
-> Detections of BTV-free animals

  1. Sentinel animals
    Serological testing of BTV-negative cattle since March 2007 (monthly)
  2. Wild animal monitoring
  3. Entomological monitoring
    - Federal territory wide
    - Morphological sorting and characterisation of gnats
    - Monitoring of the gnat pools via real-time RT-PCR
20
Q

Blue tongue disease -> Countering and control -> Immunisation

A

Use of polyvalent living vaccines in regions with multiple infections (sheeps) (unsafe, viral spread observed )

Risks: miscarriages, fetopathy; emergence of reassortants

No absolute protection, which covers all serotypes

Juridical aspects
- EU regulation of amendment
Public authorities may order vaccinations
- Merial and Intervet developed a killed vaccine; since May 2008 available (GB ordered 22,5 million doses)
- Preliminary approval of vaccine in France
approval procedure in Germany goes on, current vaccination against serotype 8 (since Mai 2008) is approved via „Dringlichkeitsverordnung“ (decree of urgency)
Vaccination does not extinct the pathogen! It only reduces viremia!

21
Q

State of vaccination

A

Spring 2008: Vaccination of cattle, sheep and goats against BTV-8 is mandatory in Germany
Since the start of the vaccination campaign on May 20 th. 2008 about 17 million doses of vaccination have been used on cattle plus about 3 million on sheeps and goats. „Nach 3 Monaten sind damit 70 Prozent der zu impfenden Rinder und fast 90 Prozent der zu impfenden Schafe und Ziegen erreicht worden. Die flächendeckende Impfung der Tiere ist damit sehr weit fortgeschritten”, declares the state secretary.
From 2010 - 2018 no new cases of BTV infection in Germany
However, in 2019 (59) and 2020 (2) cases (in south-west Germany). Vaccination therefore recommended.

22
Q

Blue tongue disease -> Summary

A

Bluetongue virus serotype 8 (BTV-8) has first been detected in Germany in August 2006. The disease reoccurred in 2007 and spread rapidly over a wide area of the country. It caused severe losses due to both clinical disease and trade restrictions. Since spring 2008, vaccination of cattle, sheep and goats against BTV-8 is mandatory. Compared with 2007 (when 20,543 new outbreaks occurred between Mai and December), the number of new outbreaks in 2008 decreased by 85 % to a total of 3,099. Actually, since Mai 2009 only seven cases of BTV-8 have been reported.

  • since 2010: Vaccination no longer mandatory
  • 2010/2011: not a single BTV case in Germany
  • since Feb. 2012: Germany is officially free of BTV
23
Q

Blue tongue disease -> Indicator of further exotic epizooties?

A

New emerging diseases
- New arboviruses due to climate change?
- Transport of animals and goods
-> Chikungunya virus transported to Italy in old tyres?
(Alphavirus: 2007 - 200 human cases in Northern Italy): Invasive Mosquitoes in Germany (trapped in July/August 2011)
Asian tiger mosquito, Aedes albopictus, an efficient vector of numerous arboviruses, was demonstrated in Germany. This mosquito species has been spreading in southern Europe for a considerable time and was made responsible for a chikungunya fever epidemic in northern Italy in 2007.

24
Q

Schmallenberg Virus

A

In summer and autumn 2011, farmers and veterinarians in North Rhine- Westphalia, Germany, and in the Netherlands reported to the animal health services, local diagnostic laboratories, and national research institutes an unidentified disease in dairy cattle with a short period of clear clinical signs, including fever, decreased milk production, and diarrhea.
The detection of a novel orthobunyavirus in cattle in Germany (Schmallenberg virus) demonstrates the power of a metagenomic approach to discovering emerging pathogens.
Specific and sensitive RT-qPCRs could be developed quickly and used in analyzing infected herds.

25
Q

Schmallenberg virus is a novel Orthobunyavirus

A

Oropouche virus is zoonotic

Shamonda virus is not reported to be zoonotic

Therefore Schmallenberg virus is not expected to have zoonotic potential

Arbo virus
- Gnats as vector
- No transmission between
mammals

26
Q

Schmallenberg Virus -> Main problem

A
  • malformation and stillbirth of offspring
  • In Deutschland wurde bisher bei Tieren aus 1910 Betrieben das Schmallenberg-Virus festgestellt. Betroffen sind 1467 Rinder-, 970 Schaf- und 50 Ziegenhaltungen.“

„Außerdem meldeten die Niederlande, Belgien, Großbritannien, Frankreich, Italien,
Luxemburg, Spanien, Dänemark und die
Schweiz Fälle von „Schmallenberg-Virus“.
In Österreich, Polen, Schweden und Finnland wurden Antikörper gegen Schmallenberg-Virus bei Rindern und Schafen bzw. Ziegen festgestellt.
In Norwegen wurde das Virus bei Gnitzen nachgewiesen.“